Holdings of Invesco Health Care Fund
AIM Investment Funds (Invesco Investment Funds) · Original filing · Compare with another fund · Report an error
- Net assets
- 1.1B $ including 1.1B $ in equities, 97.0 %
- Positions
- 77 in 7 countries
- Top ten
- 43.5 % of net assets
- Filed on
- Apr 30, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Eli Lilly & Co | 116,826 | 109.2M $ | 9.65 % |
| 2 | Johnson & Johnson | 287,695 | 66.1M $ | 5.85 % |
| 3 | AstraZeneca PLC | 252,371 | 47.3M $ | 4.18 % |
| 4 | Gilead Sciences Inc | 337,004 | 44.1M $ | 3.90 % |
| 5 | UnitedHealth Group Inc | 115,678 | 42.9M $ | 3.79 % |
| 6 | Argenx SE | 52,976 | 41.4M $ | 3.66 % |
| 7 | AbbVie Inc | 193,684 | 40.9M $ | 3.62 % |
| 8 | McKesson Corp | 47,553 | 38.8M $ | 3.43 % |
| 9 | Cencora Inc | 114,429 | 35.2M $ | 3.12 % |
| 10 | Welltower Inc | 120,441 | 26.2M $ | 2.31 % |
| 11 | Merck & Co Inc | 234,875 | 25.6M $ | 2.27 % |
| 12 | BrightSpring Health Services Inc | 482,157 | 23.1M $ | 2.04 % |
| 13 | Regeneron Pharmaceuticals, Inc. | 32,335 | 22.9M $ | 2.02 % |
| 14 | Royalty Pharma PLC | 440,990 | 22.1M $ | 1.95 % |
| 15 | Vertex Pharmaceuticals Inc | 50,958 | 21.8M $ | 1.93 % |
| 16 | Cardinal Health, Inc. | 102,628 | 19.8M $ | 1.75 % |
| 17 | HCA Healthcare Inc | 43,787 | 19M $ | 1.68 % |
| 18 | CVS Health Corp | 224,493 | 18.7M $ | 1.65 % |
| 19 | Axsome Therapeutics Inc | 87,700 | 18.2M $ | 1.61 % |
| 20 | Insmed Inc | 120,502 | 16.4M $ | 1.45 % |
| 21 | Edwards Lifesciences Corp | 192,738 | 16.1M $ | 1.42 % |
| 22 | UCB SA | 58,259 | 15.9M $ | 1.40 % |
| 23 | Bridgebio Pharma Inc | 216,227 | 15.4M $ | 1.36 % |
| 24 | Intuitive Surgical Inc | 30,687 | 14M $ | 1.24 % |
| 25 | Sandoz Group AG | 169,209 | 13.6M $ | 1.20 % |
| 26 | Mettler-Toledo International Inc | 10,479 | 13.4M $ | 1.18 % |
| 27 | Guardant Health Inc | 152,178 | 13.3M $ | 1.17 % |
| 28 | IDEXX Laboratories Inc | 23,511 | 13.2M $ | 1.17 % |
| 29 | United Therapeutics Corp | 23,038 | 13.2M $ | 1.16 % |
| 30 | Natera Inc | 63,752 | 13.1M $ | 1.16 % |
| 31 | Ascendis Pharma A/S | 54,101 | 12.4M $ | 1.10 % |
| 32 | Medline Inc | 264,708 | 11.8M $ | 1.04 % |
| 33 | Madrigal Pharmaceuticals Inc | 21,162 | 10.9M $ | 0.97 % |
| 34 | Ligand Pharmaceuticals Inc | 45,648 | 10.5M $ | 0.93 % |
| 35 | Galderma Group AG | 49,726 | 10.4M $ | 0.92 % |
| 36 | Protagonist Therapeutics Inc | 103,952 | 10.3M $ | 0.91 % |
| 37 | Halozyme Therapeutics Inc | 155,098 | 9.9M $ | 0.87 % |
| 38 | Lonza Group AG | 14,888 | 9.2M $ | 0.81 % |
| 39 | Encompass Health Corp | 87,351 | 8.7M $ | 0.77 % |
| 40 | Alignment Healthcare Inc | 384,307 | 8.7M $ | 0.77 % |
| 41 | Revolution Medicines Inc | 58,564 | 8.4M $ | 0.75 % |
| 42 | Thermo Fisher Scientific Inc | 17,604 | 8.4M $ | 0.75 % |
| 43 | Tenet Healthcare Corp | 46,569 | 8.2M $ | 0.73 % |
| 44 | Ionis Pharmaceuticals Inc | 107,312 | 8M $ | 0.71 % |
| 45 | Globus Medical Inc | 87,598 | 7.9M $ | 0.70 % |
| 46 | STERIS PLC | 33,121 | 7.2M $ | 0.64 % |
| 47 | Labcorp Holdings Inc | 27,780 | 7.1M $ | 0.63 % |
| 48 | Quest Diagnostics Inc | 35,921 | 7M $ | 0.62 % |
| 49 | LeMaitre Vascular Inc | 44,039 | 4.8M $ | 0.43 % |
| 50 | Boston Scientific Corp | 81,544 | 4.7M $ | 0.42 % |
| 51 | Arrowhead Pharmaceuticals Inc | 59,543 | 4.4M $ | 0.39 % |
| 52 | Twist Bioscience Corp | 74,708 | 4.4M $ | 0.39 % |
| 53 | BEONE MEDICINES LTD | 12,955 | 3.8M $ | 0.34 % |
| 54 | Repligen Corp | 32,126 | 3.8M $ | 0.34 % |
| 55 | Rapport Therapeutics Inc | 109,966 | 3.6M $ | 0.32 % |
| 56 | Medpace Holdings Inc | 8,661 | 3.6M $ | 0.32 % |
| 57 | HeartFlow Inc | 121,178 | 3.6M $ | 0.32 % |
| 58 | RadNet Inc | 62,732 | 3.5M $ | 0.31 % |
| 59 | TransMedics Group Inc | 33,601 | 3.4M $ | 0.30 % |
| 60 | Stryker Corp | 10,670 | 3.4M $ | 0.30 % |
| 61 | Nuvalent Inc | 33,246 | 3.3M $ | 0.29 % |
| 62 | Tarsus Pharmaceuticals Inc | 50,546 | 3.2M $ | 0.28 % |
| 63 | BioLife Solutions Inc | 151,657 | 3.2M $ | 0.28 % |
| 64 | GeneDx Holdings Corp | 50,738 | 3.2M $ | 0.28 % |
| 65 | Cytokinetics Inc | 48,114 | 3.1M $ | 0.27 % |
| 66 | Dianthus Therapeutics Inc | 33,618 | 3M $ | 0.26 % |
| 67 | Xenon Pharmaceuticals Inc | 52,646 | 3M $ | 0.26 % |
| 68 | Mirum Pharmaceuticals Inc | 29,963 | 2.9M $ | 0.26 % |
| 69 | Palvella Therapeutics Inc | 20,783 | 2.7M $ | 0.24 % |
| 70 | Cogent Biosciences Inc | 74,261 | 2.7M $ | 0.23 % |
| 71 | Rhythm Pharmaceuticals Inc | 30,683 | 2.5M $ | 0.22 % |
| 72 | Bio-Techne Corp | 44,813 | 2.5M $ | 0.22 % |
| 73 | Abivax SA | 18,814 | 2.2M $ | 0.20 % |
| 74 | Charles River Laboratories International Inc | 13,052 | 2.2M $ | 0.19 % |
| 75 | Caris Life Sciences Inc | 110,484 | 2.1M $ | 0.19 % |
| 76 | Phathom Pharmaceuticals Inc | 184,910 | 2.1M $ | 0.18 % |
| 77 | Billiontoone Inc | 14,768 | 1.1M $ | 0.10 % |
Sector breakdown
- Health care 68.2 %
- Real estate 2.4 %
- Unattributed 29.4 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- USD 95.5 %
- CHF 3.0 %
- EUR 1.4 %
The quoted currency of each line, as declared.
Country breakdown
- United States 87.0 %
- United Kingdom 4.3 %
- Netherlands 3.8 %
- Switzerland 3.0 %
- Belgium 1.4 %
- Canada 0.3 %
- France 0.2 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 69 | 954.9M $ | 86.98 % |
| 2 | United Kingdom | 1 | 47.3M $ | 4.31 % |
| 3 | Netherlands | 1 | 41.4M $ | 3.77 % |
| 4 | Switzerland | 3 | 33.2M $ | 3.02 % |
| 5 | Belgium | 1 | 15.9M $ | 1.45 % |
| 6 | Canada | 1 | 3M $ | 0.27 % |
| 7 | France | 1 | 2.2M $ | 0.20 % |
Cite this page
Titelia. "Holdings of Invesco Health Care Fund". https://titelia.com/en/funds/S000000235